Skip to main content
Premium Trial:

Request an Annual Quote

Hans Bishop

Hans Bishop has been elected to Agilent's board of directors. Bishop is cofounder, president, and CEO of Juno Therapeutics, a Seattle-based biopharmaceutical company. He has also held a range of executive positions in the pharmaceutical industry, including as COO at Dendreon; president of Specialty Medicine at Bayer Healthcare; and global commercial head for Chiron.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.